Macron promises vaccines for all, as UK refutes claims of risky vaccine drive
Issued on:
03/02/2021 - 12:35 French President Emmanuel Macron on January 5, 2021 in Tours, central France LOIC VENANCE POOL/AFP Text by: David Coffey with RFI 4 min French President Emmanuel Macron says all his countrymen who want a vaccine will be offered one by the end of the summer in a bid to offset gripes over the slow roll out of the inoculation drive. This comes as the UK has dismissed French claims of being reckless in their vaccination campaign, following criticism of the AstraZeneca vaccine being given to over-65s.
Pour Le Drian, le gazoduc Nord Stream 2 met en cause la « sécurité énergétique de l Europe » ouest-france.fr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ouest-france.fr Daily Mail and Mail on Sunday newspapers.
French health body approves AstraZeneca COVID-19 vaccine By Sudip Kar-Gupta and Geert De Clercq
FILE PHOTO: Vial and sryinge are seen in front of displayed AstraZeneca logo
PARIS (Reuters) – France’s top health advisory body on Tuesday approved the use of AstraZeneca’s COVID-19 vaccine, but said the shot should only be administered to those aged under 65.
The Haute Autorite de la Sante (HAS) said people aged 50 to 65 with health issues and medical staff should get priority access.
The decision makes AstraZeneca’s vaccine the third shot available in France, after those of Pfizer/BioNTech and Moderna.
Its recommended use for those aged below 65 echoes similar advice from experts in Italy, Austria, and Germany, which said the vaccine should not be given to the elderly, citing a lack of sufficient data to recommend use in older age groups.
FILE PHOTO: A vial and sryinge are seen in front of a displayed AstraZeneca logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
PARIS (Reuters) - France s top health advisory body on Tuesday approved the use of AstraZeneca s COVID-19 vaccine, but said the shot should only be administered to those aged under 65.
The Haute Autorite de la Sante (HAS) said people aged 50 to 65 with health issues and medical staff should get priority access.
The decision makes AstraZeneca s vaccine the third shot available in France, after those of Pfizer/BioNTech and Moderna.
Its recommended use for those aged below 65 echoes similar advice from experts in Italy, Austria, and Germany, which said the vaccine should not be given to the elderly, citing a lack of sufficient data to recommend use in older age groups.